Depression Linked to Immune Pathways Opens New Treatment Direction
Emerging research suggests shared inflammatory biology between depression and skin diseases may guide targeted therapies
New studies indicate that a subset of major depressive disorder may be driven by immune system dysregulation similar to atopic dermatitis, raising the possibility that targeted anti-inflammatory treatments could complement or reshape current approaches.
Study Details
A multidisciplinary research effort led by Helen He, MD, at the Icahn School of Medicine …
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.


